Xeris Biopharma Holdings, Inc. (XERS)
NASDAQ: XERS · Real-Time Price · USD
6.60
+1.11 (20.22%)
Aug 7, 2025, 4:00 PM - Market closed

Endeavor Group Holdings Income Statement

Millions USD. Fiscal year is Jan - Dec.
Fiscal Year
TTMFY 2024FY 2023FY 2022FY 2021FY 2020
Period Ending
Jun '25 Dec '24 Dec '23 Dec '22 Dec '21 Dec '20
246.03203.07163.91110.2549.5920.44
Revenue Growth (YoY)
35.62%23.89%48.68%122.32%142.67%650.74%
Cost of Revenue
43.736.8328.6522.6313.329.33
Gross Profit
202.33166.24135.2787.6136.2711.11
Selling, General & Admin
167.42157.38146.1137.75116.0673.73
Research & Development
27.7925.5622.3420.9725.1618.92
Operating Expenses
206.05193.78179.28169.55141.7792.65
Operating Income
-3.72-27.55-44.01-81.94-105.5-81.55
Interest Expense
-30.49-30.49-26.61-14.1-7.18-10.66
Interest & Investment Income
5.325.324.752.580.731.47
Other Non Operating Income (Expenses)
-2.040.0101.76-0.7-0.01
EBT Excluding Unusual Items
-30.92-52.7-65.87-91.7-112.66-90.75
Merger & Restructuring Charges
-----9.66-2
Gain (Loss) on Sale of Investments
-----0.41-
Legal Settlements
-----1.5
Other Unusual Items
-4.4-4.42.36-4.38--
Pretax Income
-35.32-57.1-63.5-96.08-122.73-91.25
Income Tax Expense
-3.32-2.27-1.25-1.42--0.11
Net Income
-32-54.84-62.26-94.66-122.73-91.14
Net Income to Common
-32-54.84-62.26-94.66-122.73-91.14
Shares Outstanding (Basic)
1531471381367943
Shares Outstanding (Diluted)
1531471381367943
Shares Change (YoY)
8.03%6.61%1.51%71.62%85.32%63.32%
EPS (Basic)
-0.21-0.37-0.45-0.70-1.55-2.14
EPS (Diluted)
-0.21-0.37-0.45-0.70-1.55-2.14
Free Cash Flow
--37.85-49.29-103.42-96.62-80.94
Free Cash Flow Per Share
--0.26-0.36-0.76-1.22-1.90
Gross Margin
82.24%81.86%82.52%79.47%73.14%54.35%
Operating Margin
-1.51%-13.56%-26.85%-74.32%-212.74%-399.05%
Profit Margin
-13.01%-27.00%-37.98%-85.86%-247.48%-446.00%
Free Cash Flow Margin
--18.64%-30.07%-93.80%-194.84%-396.06%
EBITDA
8.37-15.48-31.68-69.7-103.62-80.08
EBITDA Margin
3.40%-7.62%-19.33%-63.22%-208.95%-
D&A For EBITDA
12.0912.0712.3312.241.881.47
EBIT
-3.72-27.55-44.01-81.94-105.5-81.55
EBIT Margin
-1.51%-13.56%-26.85%-74.32%-212.74%-
Revenue as Reported
246.03203.07163.91110.2549.5920.44
Updated Aug 7, 2025. Source: S&P Global Market Intelligence. Standard template. Financial Sources.
SEC Filings: 10-K · 10-Q